Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zhi-Ming Zeng"'
Autor:
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji, Ling-Li Chen, Tian-Qiang Song, Wei Zhang, Zhi-Ming Zeng, Hua-Sheng Huang, Kui Wang, Lan-Qing Huang, Yong-Jun Chen, Yu-Chen Yang, Le-Du Zhou, Guo Long, Hai-Tao Zhao, Yun-Chao Wang, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC). However, the relationship between radio
Externí odkaz:
https://doaj.org/article/d2e9b4fdc6104cccbc99fee0b861c2ac
Autor:
Yong-Guang Wei, Hao Su, Zi-li Lv, Xi-Wen Liao, Zhi-Ming Zeng, Yu-Xuan Jia, Hua-Sheng Huang, Xiao-Qiang Shen, Guang-Zhi Zhu, Chuang-Ye Han, Xin-Ping Ye, Tao Peng
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundHepatocellular carcinoma (HCC) with a dismal prognosis is the second most deadly malignancy globally. Surgery is believed to be a curative approach. Nevertheless, there is still a considerable probability of postoperative recurrence. Most p
Externí odkaz:
https://doaj.org/article/8d6b0071ea89408196a1f9a4d5f0fc9e
Autor:
Bin Xu, Sanyuan Dong, Xue-Li Bai, Tian-Qiang Song, Bo-Heng Zhang, Le-Du Zhou, Yong-Jun Chen, Zhi-Ming Zeng, Kui Wang, Hai-Tao Zhao, Na Lu, Wei Zhang, Xu-Bin Li, Su-Su Zheng, Guo Long, Yu-Chen Yang, Hua-Sheng Huang, Lan-Qing Huang, Yun-Chao Wang, Fei Liang, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Meng-Su Zeng, Jia Fan, Sheng-Xiang Rao, Hui-Chuan Sun
Publikováno v:
Liver Cancer (2022)
Introduction: Lenvatinib plus an anti–PD-1 antibody has shown promising anti-tumor effects in patients with advanced hepatocellular carcinoma (HCC), but with clinical benefit limited to a subset of patients. We developed and validated a radiomic-ba
Externí odkaz:
https://doaj.org/article/8ffc70f4b79c4d9794e9ade6e626e051
Autor:
Zhi-Ming Zeng, Ning Mo, Jie Zeng, Fu-Chao Ma, Yan-Feng Jiang, Hua-Sheng Huang, Xi-Wen Liao, Guang-Zhi Zhu, Jie Ma, Tao Peng
Publikováno v:
World journal of gastrointestinal oncology. 14(9)
Hepatocellular carcinoma (HCC) is a highly heterogeneous, invasive, and conventional chemotherapy-insensitive tumor with unique biological characteristics. The main methods for the radical treatment of HCC are surgical resection or liver transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec16cd971b0182c46bd1f1a44604fc05
https://pubmed.ncbi.nlm.nih.gov/36187393
https://pubmed.ncbi.nlm.nih.gov/36187393
Publikováno v:
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 26(2)
Exosomes derived from hepatocellular carcinoma (HCC) cells are nanovesicles and are involved in the occurrence and development of HCC, they also serve as important carriers and drug targets of nanodrug delivery systems. The external shape and interna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0380ea420c205d1c36cf50078338516
https://pubmed.ncbi.nlm.nih.gov/32051051
https://pubmed.ncbi.nlm.nih.gov/32051051
Autor:
Zhi-ming Zeng1, Fei-fei Luo2, Lin-xia Zou3, Rong-quan He1, Deng-hua Pan2, Xin Chen2, Ting-ting Xie2, Yuan-qing Li2, Zhi-gang Peng1, Gang Chen2 chen_gang_triones@163.com
Publikováno v:
OncoTargets & Therapy. Nov2016, Vol. 9, p7105-7114. 10p.
Autor:
Fu-Chao Ma, Qian Yu, Zhi-Ming Zeng, Rong-Quan He, Chao-Hua Mo, Jin-Cai Zhong, Jie Ma, Zhen-Bo Feng, Gang Chen, Xiao-Hua Hu
Publikováno v:
OncoTargets & Therapy; Nov2017, Vol. 10, p5237-5242, 6p, 5 Black and White Photographs, 1 Diagram